ReAx Therapeutics

Notes

ReAx Therapeutics is developing a next-generation chemoproteomics platform which leverages chemical and biological insights to identify and target novel hotspots across the proteome in disease-relevant contexts. The platform enables drug discovery against challenging targets by understanding protein function at the chemical level.

Note: This may be related to or the same entity as ReAx Biotechnologies. Limited public information available.

Additional Research Findings

• Chemoproteomics platform for drug discovery
• Focus on identifying novel protein targets
• Targeting disease-relevant proteome hotspots
• Part of growing chemoproteomic drug discovery space

Sources

• Company information from industry databases